Pembroke Pines, FL, United States of America

Scott M Malinconico

This inventor holds 1 USPTO granted patent. Top assignee: Coulter Corporation. Active years: 1989.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Scott M Malinconico: Innovator in Immunological Assays

Introduction

Scott M Malinconico is a notable inventor based in Pembroke Pines, FL (US). He has made significant contributions to the field of immunology through his innovative patent. His work focuses on enhancing the accuracy of immunofluorescent and immunohistochemical assays.

Latest Patents

Scott M Malinconico holds a patent for a chemical blocking agent designed to prevent non-specific binding or staining of antibodies specific for Terminal deoxynucleotidyl Transferase (TdT). This chemical agent plays a crucial role in improving the reliability of assay procedures, which include both immunofluorescent and immunoperoxidase techniques. The invention utilizes casein, introduced at an appropriate interval prior to analysis, to effectively block non-specific staining, thereby enhancing the clarity of results obtained through flow cytometric and microscopic analysis.

Career Highlights

Malinconico is associated with Coulter Corporation, where he has applied his expertise in developing innovative solutions for immunological testing. His work has contributed to advancements in the accuracy and efficiency of laboratory procedures.

Collaborations

Throughout his career, Scott has collaborated with esteemed colleagues, including Kenneth H Kortright and R Graham Smith. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Scott M Malinconico's contributions to the field of immunology through his patent demonstrate his commitment to advancing scientific research and improving laboratory practices. His innovative approach continues to influence the development of more reliable immunological assays.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…